Thomas Jefferson University Hospital
Background data
Program Type : Adult ProgramFACT Approved: Yes
Year CAR T-cell Therapy Program Opened:
Location Info
Thomas Jefferson University HospitalDivision of Transplant and Cellular Therapy Program
1025 Walnut Street, Suite 726
Philadelphia, , 19107
Philadelphia, , 19107
Website : https://www.jeffersonhealth.org/conditions-and-treatments/bone-marrow-transplant
CAR T-cell therapies performed
Numbers displayed are the most recent data provided by this center.| Year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Number performed | 10 | 16 | 25 | 29 | 55 |
Program Director
| Name | Phone |
|---|---|
| Usama Gergis, MD, MBA | (215) 955-8874 |
Medical Director
| Name | Phone |
|---|---|
| Usama Gergis, MD, MBA | (215) 955-8874 |
Physician
| Name | Phone |
|---|---|
| Seyfettin Onder Alpdogan, MD | (215) 955-8874 |
| Xia Bi, MD | (215) 955-8874 |
| Adam Binder, MD | (215) 955-8874 |
| Joanne Filicko-O'Hara, MD | (215) 955-8874 |
| Beatrice Razzo, MD | (215) 955-8874 |
| Joseph Van Galen, MD | (215) 955-8874 |
Coordinator
| Name | Phone |
|---|---|
| Christina Dolson, BSN, RN, OCN | (215) 955-8874 |
| Lisa Morano, BSN, RN | (215) 955-8874 |
| Nikita Nayee, MSN, RN | (215) 955-8874 |
| Michele Palladino, BSN, RN | (215) 955-8874 |
Diseases treated by CAR T-cell therapy
- Leukemia, acute lymphoblastic
- Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
CAR T-Cell products
- Abecma (idecabtagene vicleucil, ide-cel)
- Breyanzi (lisocabtagene maraleucel, liso-cel)
- Kymriah (tisagenlecleucel, tisa-cel)
- Tecartus (brexucabtagene autoleucel, brexu-cel)
- Yescarta (axicabtagene ciloleucel, axi-cel)